Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma

Burkitt lymphoma (BL) is a highly aggressive B-cell lymphoma associated with MYC translocation. Here, we describe drug response profiling of 42 blood cancer cell lines including 17 BL to 32 drugs targeting key cancer pathways and provide a systematic study of drug combinations in BL cell lines. Base...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomska, K., Kurilov, R., Lee, K. S., Hüllein, J., Lukas, M., Sellner, L., Walther, T., Wagner, L., Oleś, M., Brors, B., Huber, W., Zenz, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089937/
https://www.ncbi.nlm.nih.gov/pubmed/30104685
http://dx.doi.org/10.1038/s41598-018-30509-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089937/
https://www.ncbi.nlm.nih.gov/pubmed/30104685
http://dx.doi.org/10.1038/s41598-018-30509-3

Ejemplares similares